Idera Pharmaceuticals initiated with Market Perform

JMP Securities analyst Michael King initiated coverage of Idera Pharmaceuticals Inc. (Nasdaq: IDRA) with a Market Outperform rating and a price target of $8 sending the stock price up 40 cents to close at $2.49.



Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.